{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:02:46Z","timestamp":1771261366038,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,13]]},"abstract":"<jats:p>Myasthenia gravis (MG) is an autoimmune neuromuscular junction disease classified as early onset MG (EOMG), which typically occurs before the age of 50 years, and late-onset MG (LOMG), which occurs after the age of 50 years. The contribution of different immune cell subsets to MG pathogenesis is not fully understood. To address this, we conducted 2-sample Mendelian randomization (MR) analyses incorporating 731 peripheral immunophenotypes associated with MG. To further explore cellular mechanisms, we analyzed an existing single-cell RNA sequencing (scRNA-seq) dataset derived from the peripheral blood of patients with MG during and after the myasthenic crisis phase. In MR analyses, IVW results suggested that 42 immunophenotypes were risk or protective factors for LOMG, whereas 28 immunophenotypes were involved in EOMG. Comprehensive sensitivity analyses confirmed the absence of heterogeneity and horizontal pleiotropy. Among these, the proportion of effector memory CD4\u2005+\u2005T cells emerged as the most significant factor associated with an increased risk of LOMG. Single-cell analyses revealed an expansion of these cells in patients with LOMG during the myasthenic crisis stage compared with the stable stage, with functional annotations showing strong similarities to activated CD4\u2005+\u2005T cells treated with TGF-\u03b2 and IL-4. This study identified effector memory CD4\u2005+\u2005T cells as a significant risk factor for LOMG through MR analyses and further explored an existing scRNA-seq dataset. The role of effector memory CD4\u2005+\u2005T cells, potentially mediated by TGF-\u03b2 and IL-4, in LOMG pathogenesis and disease exacerbation, highlighting the need for further functional studies.<\/jats:p>","DOI":"10.1097\/md.0000000000047588","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:00:29Z","timestamp":1771005629000},"page":"e47588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mendelian randomization followed by single-cell RNA sequencing exploration identifies effector memory CD4+ T cells as a risk factor for myasthenia gravis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4608-4727","authenticated-orcid":false,"given":"Zhaolin","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Neurology, Yuexi Hospital of the Sixth Affiliated Hospital, Sun Yat-sen University (Xinyi People\u2019s Hospital), Xinyi, Guangdong, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"He","sequence":"additional","affiliation":[{"name":"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichun","family":"Cai","sequence":"additional","affiliation":[{"name":"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijun","family":"Li","sequence":"additional","affiliation":[{"name":"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-6534","authenticated-orcid":false,"given":"Haihong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260216","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis.","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"R2-20260216","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/JS9.0000000000000164","article-title":"Myasthenia gravis in current status: epidemiology, types, etiology, pathophysiology, symptoms, diagnostic tests, prevention, treatment, and complications \u2013 correspondence.","volume":"109","author":"Rahman","year":"2023","journal-title":"Int J Surg"},{"key":"R3-20260216","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low\u2010density lipoprotein receptor\u2013related protein 4 in myasthenia gravis.","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"R4-20260216","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"R5-20260216","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","article-title":"International consensus guidance for management of myasthenia gravis: 2020 update.","volume":"96","author":"Narayanaswami","year":"2021","journal-title":"Neurology"},{"key":"R6-20260216","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41582-023-00916-w","article-title":"Myasthenia gravis: the changing treatment landscape in the era of molecular therapies.","volume":"20","author":"Iorio","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"R7-20260216","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease.","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"R8-20260216","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41421-021-00314-w","article-title":"Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis.","volume":"7","author":"Jin","year":"2021","journal-title":"Cell Discov"},{"key":"R9-20260216","doi-asserted-by":"crossref","first-page":"109184","DOI":"10.1016\/j.clim.2022.109184","article-title":"Single-cell mapping reveals dysregulation of immune cell populations and VISTA+ monocytes in myasthenia gravis.","volume":"245","author":"Fan","year":"2022","journal-title":"Clin Immunol"},{"key":"R10-20260216","doi-asserted-by":"crossref","first-page":"e26741","DOI":"10.1016\/j.heliyon.2024.e26741","article-title":"Causal relationship between the immune phenotype of monocytes and myasthenia gravis: a Mendelian randomization study.","volume":"10","author":"Dong","year":"2024","journal-title":"Heliyon"},{"key":"R11-20260216","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/acn3.51312","article-title":"In\u2010depth peripheral CD4 + T profile correlates with myasthenic crisis.","volume":"8","author":"Huan","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"R12-20260216","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12967-023-04421-y","article-title":"Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics.","volume":"21","author":"Zhong","year":"2023","journal-title":"J Transl Med"},{"key":"R13-20260216","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.26169","article-title":"Genomic insights into myasthenia gravis identify distinct immunological mechanisms in early and late onset disease.","volume":"90","author":"Handunnetthi","year":"2021","journal-title":"Ann Neurol"},{"key":"R14-20260216","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R15-20260216","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R16-20260216","doi-asserted-by":"crossref","first-page":"e8746","DOI":"10.15252\/msb.20188746","article-title":"Current best practices in single\u2010cell RNA\u2010seq analysis: a tutorial.","volume":"15","author":"Luecken","year":"2019","journal-title":"Mol Syst Biol"},{"key":"R17-20260216","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R18-20260216","doi-asserted-by":"crossref","first-page":"e2108672119","DOI":"10.1073\/pnas.2108672119","article-title":"Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.","volume":"119","author":"Chia","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-20260216","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"R20-20260216","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R21-20260216","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: a database of human genotype\u2013phenotype associations.","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"R22-20260216","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype\u2013phenotype associations.","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"R23-20260216","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ije\/dyy258","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R24-20260216","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R25-20260216","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R26-20260216","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R27-20260216","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R28-20260216","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R29-20260216","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data.","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"R30-20260216","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data.","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"R31-20260216","doi-asserted-by":"crossref","first-page":"D870","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data.","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R32-20260216","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R33-20260216","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0006-3223(98)00043-2","article-title":"Multiple correlations and bonferroni\u2019s correction.","volume":"44","author":"Curtin","year":"1998","journal-title":"Biol Psychiatry"},{"key":"R34-20260216","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.","volume":"203","author":"Uzawa","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"R35-20260216","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11481-021-10030-7","article-title":"Increased expression of CD95 in CD4+ effector memory T cells promotes Th17 response in patients with myasthenia gravis.","volume":"17","author":"Huang","year":"2022","journal-title":"J Neuroimmune Pharmacol"},{"key":"R36-20260216","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","article-title":"CD4+ T cell memory.","volume":"24","author":"K\u00fcnzli","year":"2023","journal-title":"Nat Immunol"},{"key":"R37-20260216","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1212\/NXI.0000000000000945","article-title":"Immune skew of circulating follicular helper T cells associates with myasthenia gravis severity.","volume":"8","author":"Ashida","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R38-20260216","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2020.00809","article-title":"CD4+ T cells of myasthenia gravis patients are characterized by increased IL-21, IL-4, and IL-17A productions and higher presence of PD-1 and ICOS.","volume":"11","author":"\u00c7ebi","year":"2020","journal-title":"Front Immunol"},{"key":"R39-20260216","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fneur.2018.00529","article-title":"IL-4R\u03b1 polymorphism is associated with myasthenia gravis in chinese han population.","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Neurol"},{"key":"R40-20260216","doi-asserted-by":"crossref","first-page":"108760","DOI":"10.1016\/j.pharmthera.2024.108760","article-title":"Healing action of Interleukin-4 (IL-4) in acute and chronic inflammatory conditions: mechanisms and therapeutic strategies.","volume":"265","author":"Pan","year":"2025","journal-title":"Pharmacol Therap"},{"key":"R41-20260216","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21505594.2020.1726569","article-title":"Balancing in a black box: potential immunomodulatory roles for TGF-\u03b2 signaling during blood-stage malaria.","volume":"11","author":"Drewry","year":"2020","journal-title":"Virulence"},{"key":"R42-20260216","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2249.2002.01748.x","article-title":"Dendritic cells exposed in vitro to TGF-\u03b21 ameliorate experimental autoimmune myasthenia gravis.","volume":"127","author":"Yarilin","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R43-20260216","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","article-title":"The role of the TGF-\u03b2 superfamily in myocardial infarction.","volume":"6","author":"Hanna","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"R44-20260216","doi-asserted-by":"crossref","first-page":"e8706","DOI":"10.1371\/journal.pone.0008706","article-title":"Human CD4+ memory T cells can become CD4+IL-9+ T Cells.","volume":"5","author":"Putheti","year":"2010","journal-title":"PLoS One"},{"key":"R45-20260216","doi-asserted-by":"crossref","first-page":"e26359","DOI":"10.1016\/j.heliyon.2024.e26359","article-title":"Regulatory role of T helper 9\/interleukin-9: transplantation view.","volume":"10","author":"Roostaee","year":"2024","journal-title":"Heliyon"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:01:59Z","timestamp":1771257719000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047588","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"2025-06-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}